Patogénesis, manifestaciones y objetivo terapéutico | 10 FEB 19

Síndrome de superposición Asma-EPOC

Afecta hasta la cuarta parte de los pacientes con diagnóstico previo de EPOC y hasta un tercio de los pacientes con asma. Se evalúan las hipótesis divergentes: ¿es un espectro o son dos enfermedades distintas?
Autor/a: Janice M Leung. D Sin BMJ 2017;358:j3772
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1 Orie NG, Sluiter HJ. Bronchitis.Charles C Thomas, 1961.

2 Barnes PJ. Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am J Respir Crit Care Med 2006;174:240-3, discussion 243-4. doi:10.1164/ rccm.2604008 pmid:16864717.

3 Kraft M. Asthma and chronic obstructive pulmonary disease exhibit common origins in any country!Am J Respir Crit Care Med 2006;174:238- 40, discussion 243-4. doi:10.1164/rccm.2604007 pmid:16864716.

4 Vermeire PA, Pride NBA. A “splitting” look at chronic nonspecific lung disease (CNSLD): common features but diverse pathogenesis. Eur Respir J 1991;4:490-6.pmid:1855578.

5 Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PLoS One 2015;10:e0136065. doi:10.1371/journal. pone.0136065 pmid:26336076.

6 Goto T, Camargo CA Jr, , Hasegawa K. Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome: analysis of the National Health and Nutrition Examination Survey, 2007-2012. Int J Chron Obstruct Pulmon Dis 2016;11:2149-55. doi:10.2147/COPD.S110879 pmid:27660432.

7 Ding B, DiBonaventura M, Karlsson N, Ling X. Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys. Int J Chron Obstruct Pulmon Dis 2016;11:1139-50.pmid:27354777.

8 To T, Zhu J, Larsen K, et al. Canadian Respiratory Research Network. Progression from Asthma to Chronic Obstructive Pulmonary Disease. Is Air Pollution a Risk Factor?Am J Respir Crit Care Med 2016;194:429-38. doi:10.1164/rccm.201510-1932OC pmid:26950751.

9 Woodruff PG, van den Berge M, Boucher RC, et al. American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report. Am J Respir Crit Care Med 2017;196:375-81. doi:10.1164/rccm.201705- 0973WS pmid:28636425.

10 Kurashima K, Takaku Y, Ohta C, Takayanagi N, Yanagisawa T, Sugita Y. COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 2016;11:479-87. doi:10.2147/COPD. S97343 pmid:27019598.

11 Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011;48:279-85. doi:10.3109/02770903.2011.555576 pmid:21323613.

12 de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One 2013;8:e62985. doi:10.1371/journal. pone.0062985 pmid:23675448.

 

Andersén H, Lampela P, Nevanlinna A, Säynäjäkangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J 2013;7:342-6. doi:10.1111/crj.12013 pmid:23362945.

14 Bai JW, Mao B, Yang WL, Liang S, Lu HW, Xu JF. Asthma-COPD overlap syndrome showed more exacerbations however lower mortality than COPD. QJM 2017;pii:hcx005. doi:10.1093/qjmed/ hcx005 pmid:28100824.

15 Kim MA, Noh CS, Chang YJ, et al. Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation. Int J Tuberc Lung Dis 2015;19:864-9. doi:10.5588/ijtld.14.0327 pmid:26056115.

16 Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J 2014;44:341-50. doi:10.1183/09031936.00216013 pmid:24876173.

17 Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 2016;48:664-73. doi:10.1183/13993003.00436- 2016 pmid:27338195.

18 Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it?Thorax 2009;64:728-35. doi:10.1136/thx.2008.108027 pmid:19638566.

19 Global Initiative for Asthma. Global strategy for asthma management and prevention. 2015 http://ginasthma.org/wp-content/uploads/2016/01/ GINA_Report_2015_Aug11-1.pdf.

20 Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012;48:331-7. doi:10.1016/j.arbr.2012.06.017 pmid:22341911.

21 Cosio BG, Soriano JB, López-Campos JL, et al. CHAIN Study. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. Chest 2016;149:45- 52. doi:10.1378/chest.15-1055 pmid:26291753.

22 Koblizek V, Chlumsky J, Zindr V, et al. Czech Pneumological and Phthisiological Society. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013;157:189-201.pmid:23733084.

23 Cataldo D, Corhay JL, Derom E, et al. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 2017;12:601-13. doi:10.2147/COPD.S124459 pmid:28243078.

24 Jin J, Liu X, Sun Y. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function. Respir Res 2014;15:130. doi:10.1186/s12931-014- 0130-1 pmid:25359094.

25 Tamada T, Sugiura H, Takahashi T, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis 2015;10:2169-76. doi:10.2147/COPD. S88274 pmid:26491283.

26 Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012;186:48-55. doi:10.1164/rccm.201108- 1553OC pmid:22447964.

27 Oshagbemi OA, Burden AM, Braeken DC, et al. Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Count. Am J Respir Crit Care Med 2017;195:1402-4. doi:10.1164/ rccm.201701-0009LE pmid:28165763.

28 Couillard S, Larivée P, Courteau J, Vanasse A. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions. Chest 2017;151:366-73. doi:10.1016/j. chest.2016.10.003 pmid:27746201.

29 Pavord ID, Lettis S, Anzueto A, Barnes N. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. Lancet Respir Med 2016;4:731-41. doi:10.1016/S2213-2600(16)30148-5 pmid:27460163.

30 Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med 2016;4:390-8. doi:10.1016/S2213- 2600(16)00100-4 pmid:27066739.

31 Pavord ID, Lettis S, Locantore N, et al. Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax 2016;71:118-25. doi:10.1136/ thoraxjnl-2015-207021 pmid:26585525.

32 Hasegawa K, Camargo CA Jr. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD. Respirology 2016;21:761-4. doi:10.1111/resp.12724 pmid:26699685.

33 Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010;79:147-51. doi:10.1159/000245899 pmid:19816004.

34 Akamatsu K, Matsunaga K, Sugiura H, et al. Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?Front Pharmacol 2011;2:36. doi:10.3389/ fphar.2011.00036 pmid:21811461.

35 Chen FJ, Huang XY, Liu YL, Lin GP, Xie CM. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2385-90. doi:10.2147/COPD.S115378 pmid:27713629.

 

36 Rossall MR, Cadden PA, Molphy SD, Plumb J, Singh D. Repeatability of induced sputum measurements in moderate to severe asthma. Respir Med 2014;108:1566-8. doi:10.1016/j. rmed.2014.08.004 pmid:25195138.

37 Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012;67:199-208. doi:10.1136/thx.2010.135574 pmid:20937641.

38 Gochicoa-Rangel L, Rojas-Cisneros F, Miguel-Reyes JL, et al. Variability of FeNO in healthy subjects at 2240 meters above sea level. J Clin Monit Comput 2016;30:445-9. doi:10.1007/s10877-015-9737- 0 pmid:26174797.

39 Kapande KM, McConaghy LA, Douglas I, et al. Comparative repeatability of two handheld fractional exhaled nitric oxide monitors. Pediatr Pulmonol 2012;47:546-50. doi:10.1002/ppul.21591 pmid:22038831.

40 de Marco R, Marcon A, Rossi A, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J 2015;46:671- 9. doi:10.1183/09031936.00008615 pmid:26113674.

41 Chung JW, Kong KA, Lee JH, Lee SJ, Ryu YJ, Chang JH. Characteristics and self-rated health of overlap syndrome. Int J Chron Obstruct Pulmon Dis 2014;9:795-804.pmid:25092973.

42 Kumbhare S, Pleasants R, Ohar JA, Strange C. Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States. Ann Am Thorac Soc 2016;13:803-10. doi:10.1513/ AnnalsATS.201508-554OC pmid:26974689.

43 Menezes AMB, Montes de Oca M, Pérez-Padilla R, et al. PLATINO Team. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014;145:297-304. doi:10.1378/chest.13-0622 pmid:24114498.

44 Pleasants RA, Ohar JA, Croft JB, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD 2014;11:256-66.pmid:24152212.

45 Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD 2011;8:400-7. doi:10.3109/15412555.2011.611200 pmid:22149399.

46 Bui DS, Burgess JA, Lowe AJ, et al. Childhood Lung Function Predicts Adult Chronic Obstructive Pulmonary Disease and Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome. Am J Respir Crit Care Med 2017;196:39-46. doi:10.1164/rccm.201606- 1272OC pmid:28146643.

47 Wheaton AG, Pleasants RA, Croft JB, et al. Gender and asthma-chronic obstructive pulmonary disease overlap syndrome. J Asthma 2016;53:720- 31. doi:10.3109/02770903.2016.1154072 pmid:27043854.

48 Tkacova R, Dai DL, Vonk JM, et al. Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?J Allergy Clin Immunol 2016;138:1571-9. doi:10.1016/j.jaci.2016.04.022 pmid:27345171.

49 Baarnes CB, Kjeldgaard P, Nielsen M, Miravitlles M, Ulrik CS. Identifying possible asthma-COPD overlap syndrome in patients with a new diagnosis of COPD in primary care. NPJ Prim Care Respir Med 2017;27:16084. doi:10.1038/npjpcrm.2016.84 pmid:28055002.

50 Caillaud D, Chanez P, Escamilla R, et al. Initiatives BPCO scientific committee and investigators. Asthma-COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype?Allergy 2017;72:137-45. doi:10.1111/all.13004 pmid:27501862.

51 Miravitlles M, Huerta A, Fernández-Villar JA, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes 2014;12:120. doi:10.1186/ s12955-014-0120-5 pmid:25189786.

52 Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis 2012;7:283-9.pmid:22589579.

53 Hardin M, Silverman EK, Barr RG, et al. COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127. doi:10.1186/1465-9921-12-127 pmid:21951550.

54 Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax 2008;63:761-7. doi:10.1136/ thx.2007.089193 pmid:18728201.

55 Sorino C, Pedone C, Scichilone N. Fifteen-year mortality of patients with asthma-COPD overlap syndrome. Eur J Intern Med 2016;34:72-7. doi:10.1016/j.ejim.2016.06.020 pmid:27357368.

56 Wurst KE, Rheault TR, Edwards L, Tal-Singer R, Agusti A, Vestbo J. A comparison of COPD patients with and without ACOS in the ECLIPSE study. Eur Respir J 2016;47:1559-62. doi:10.1183/13993003.02045- 2015 pmid:26989103.

57 Kobayashi S, Hanagama M, Yamanda S, Ishida M, Yanai M. Inflammatory biomarkers in asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 2016;11:2117-23. doi:10.2147/COPD. S113647 pmid:27660429.

58 Chung WS, Lin CL, Kao CH. Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients: a population-based cohort study. Medicine (Baltimore) 2015;94:e755. doi:10.1097/MD.0000000000000755 pmid:25929911.

59 Milanese M, Di Marco F, Corsico AG, et al. ELSA Study Group. Asthma control in elderly asthmatics. An Italian observational study. Respir Med 2014;108:1091-9. doi:10.1016/j.rmed.2014.05.016 pmid:24958604.

 

60 Ozkaya S, Dirican A, Tuna T. The objective evaluation of obstructive pulmonary diseases with spirometry. Int J Chron Obstruct Pulmon Dis 2016;11:2009-15. doi:10.2147/COPD.S113774 pmid:27616884.

61 Vaz Fragoso CA, Murphy TE, Agogo GO, Allore HG, McAvay GJ. Asthma- COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization. Int J Chron Obstruct Pulmon Dis 2017;12:517-27. doi:10.2147/COPD. S121223 pmid:28223792.

62 Fu JJ, Gibson PG, Simpson JL, McDonald VM. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration 2014;87:63-74. doi:10.1159/000352053 pmid:24029561.

63 van Boven JF, Román-Rodríguez M, Palmer JF, Toledo- Pons N, Cosío BG, Soriano JB. Comorbidome, Pattern, and Impact of Asthma-COPD Overlap Syndrome in Real Life. Chest 2016;149:1011-20. doi:10.1016/j.chest.2015.12.002 pmid:26836892.

64 Cosentino J, Zhao H, Hardin M, et al. COPDGene Investigators. Analysis of Asthma-Chronic Obstructive Pulmonary Disea|se Overlap Syndrome Defined on the Basis of Bronchodilator Response and Degree of Emphysema. Ann Am Thorac Soc 2016;13:1483-9. doi:10.1513/ AnnalsATS.201511-761OC pmid:27268723.

65 Nielsen M, Bårnes CB, Ulrik CS. Clinical characteristics of the asthma- COPD overlap syndrome--a systematic review. Int J Chron Obstruct Pulmon Dis 2015;10:1443-54.pmid:26251584.

66 Kitaguchi Y, Yasuo M, Hanaoka M. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation. Int J Chron Obstruct Pulmon Dis 2016;11:991-7. doi:10.2147/COPD.S105988 pmid:27274220.

67 Suzuki T, Tada Y, Kawata N, et al. Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis 2015;10:947- 54.pmid:26028967.

68 Lange P, Çolak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med 2016;4:454-62. doi:10.1016/S2213-2600(16)00098- 9 pmid:27061878.

69 Wurst KE, St Laurent S, Hinds D, Davis KJ. Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions. COPD 2017;14:200-9. doi:10.1080/15412555.2016.1257598 pmid:28103123.

70 Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Tunceli O. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone. Value Health 2015;18:759-66. doi:10.1016/j.jval.2015.04.010 pmid:26409602.

71 Rhee CK, Yoon HK, Yoo KH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 2014;11:163-70. doi:10.3109/15412555.2013.831061 pmid:24111662.

72 Sadatsafavi M, Tavakoli H, Kendzerska T, et al. Canadian Respiratory Research Network. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden. Ann Am Thorac Soc 2016;13:188-96.pmid:26599154.

73 Yamauchi Y, Yasunaga H, Matsui H, et al. Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology 2015;20:940-6. doi:10.1111/ resp.12556 pmid:25998444.

74 Sluiter HJ, Koëter GH, de Monchy JG, Postma DS, de Vries K, Orie NG. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J 1991;4:479-89.pmid:1855577.

75 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-121.pmid:7582322.

76 O’Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006;15:61- 7doi:10.1183/09059180.00010002.

77 Gelb AF, Yamamoto A, Verbeken EK, Nadel JA. Unraveling the Pathophysiology of the Asthma-COPD Overlap Syndrome: Unsuspected Mild Centrilobular Emphysema Is Responsible for Loss of Lung Elastic Recoil in Never Smokers With Asthma With Persistent Expiratory Airflow Limitation. Chest 2015;148:313-20. doi:10.1378/chest.14- 2483 pmid:25950858.

78 Mauad T, Silva LF, Santos MA, et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med 2004;170:857-62. doi:10.1164/rccm.200403- 305OC pmid:15151920.

79 Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004;24:822-33. doi:10.1183/09031936.04.00039004 pmid:15516679.

80 Yii AC, Tan GL, Tan KL, Lapperre TS, Koh MS. Fixed airways obstruction among patients with severe asthma: findings from the Singapore General Hospital-Severe Asthma Phenotype Study. BMC Pulm Med 2014;14:191. doi:10.1186/1471-2466-14-191 pmid:25467558.

81 Tan DJ, Walters EH, Perret JL, et al. Clinical and functional differences between early-onset and late-onset adult asthma: a population-based Tasmanian Longitudinal Health Study. Thorax 2016;71:981-7. doi:10.1136/thoraxjnl-2015-208183 pmid:27301974.

 

82 Kiljander T, Helin T, Venho K, Jaakkola A, Lehtimäki L. Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study. NPJ Prim Care Respir Med 2015;25:15047. doi:10.1038/npjpcrm.2015.47 pmid:26182124.

83 Broekema M, ten Hacken NH, Volbeda F, et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009;180:1170-8. doi:10.1164/rccm.200906- 0828OC pmid:19797761.

84 Boulet LP, Lemière C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006;129:661-8. doi:10.1378/ chest.129.3.661 pmid:16537865.

85 Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001;120:1917-22. doi:10.1378/chest.120.6.1917 pmid:11742922.

86 Siew LQC, Wu SY, Ying S, Corrigan CJ. Cigarette smoking increases bronchial mucosal IL-17A expression in asthmatics, which acts in concert with environmental aeroallergens to engender neutrophilic inflammation. Clin Exp Allergy 2017;47:740-50. doi:10.1111/ cea.12907 pmid:28211191.

87 St-Laurent J, Bergeron C, Pagé N, Couture C, Laviolette M, Boulet LP. Influence of smoking on airway inflammation and remodelling in asthma. Clin Exp Allergy 2008;38:1582-9. doi:10.1111/j.1365- 2222.2008.03032.x pmid:18681853.

88 Shimoda T, Obase Y, Kishikawa R, Iwanaga T. Influence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthma. Allergy Asthma Proc 2016;37:50-8. doi:10.2500/ aap.2016.37.3944 pmid:27401308.

89 Huang CC, Wang CH, Fu CH, et al. Association between cigarette smoking and interleukin-17A expression in nasal tissues of patients with chronic rhinosinusitis and asthma. Medicine (Baltimore) 2016;95:e5432. doi:10.1097/MD.0000000000005432 pmid:27893686.

90 Ravensberg AJ, Slats AM, van Wetering S, et al. CD8(+) T cells characterize early smoking-related airway pathology in patients with asthma. Respir Med 2013;107:959-66. doi:10.1016/j. rmed.2013.03.018 pmid:23639272.

91 Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:711-7. doi:10.1164/ ajrccm.160.2.9812020 pmid:10430750.

92 O’Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997;155:852-7. doi:10.1164/ajrccm.155.3.9117016 pmid:9117016.

93 den Otter I, Willems LN, van Schadewijk A, et al. Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells. Eur Respir J 2016;48:393-402. doi:10.1183/13993003.01525- 2015 pmid:27230446.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024